Page 18 - Brain Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ryoichiro Kageyama from the RIKEN Center for Brain Science says their work developing optogenetic, gene editing and bioinformatic technologies, as

As medical advances help individuals with HIV survive longer, there is an increasing need to treat their chronic symptoms. One of the most common is

WASHINGTON -- Georgetown University researchers, looking at the ability of people to sound out words after a stroke, found that knowing which region of...

Amyotrophic lateral sclerosis (ALS), often known as motor neurone disease, slowly kills off nerve cells in the brain and spinal cord, causing paralysis and eventually death.

 E-Mail The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed. For the study, published in Brain Communications, clinicians evaluated the use of K.Vita®, (also known as Betashot), an oral liquid dietary supplement developed by UCL in collaboration with Royal Holloway, University of London, and Vitaflo International Ltd. The ketogenic diet (KD) consists of high-fat, low-carbohydrate and adequate protein consumption and mimics the fasting stat...